The following is a statement from the Society for Maternal-Fetal Medicine, the American College of Obstetricians and Gynecologists, the American Society for Reproductive Medicine, the National Abortion Federation, the National Association of Nurse Practitioners in Women's Health, the National Society of Genetic Counselors, Nurses for Sexual and Reproductive Health, and the Society of Family Planning, in response to the recent legal activity in Louisiana v. FDA: 

“Our organizations reaffirm that mifepristone is a safe, effective, and integral part of the healthcare our members provide to their patients. We strongly oppose unnecessary and burdensome restrictions on mifepristone, including the in-person requirements that were temporarily imposed last week in Louisiana v. FDA. We are grateful that the Supreme Court of the United States blocked the Fifth Circuit ruling, temporarily protecting access to mifepristone, and we urge the Supreme Court to maintain its order beyond the end of the week. 

"Rigorous clinical evidence and decades of use by millions of patients have proven unequivocally that mifepristone is safe and effective for use in medication abortion and miscarriage management. Complications are typically minor and exceedingly rare. Despite these facts, mifepristone has been under intense legal scrutiny in litigation aimed at removing access to this lifesaving medication nationwide. The ruling from the Fifth Circuit is the most recent example.  

"In-person fulfillment requirements for mifepristone do nothing to enhance or ensure the safety of a drug already deemed safe. Rather, they impose medically unnecessary burdens, lead to delays in care, and worsen health inequities for patients across the country.  

"Healthcare access must be based on scientific evidence, not political or personal ideology. The overwhelming scientific evidence demonstrates that mifepristone is safe, effective, and critical to patient care. Mifepristone must be accessible to all whose health and lives will benefit from it.”

#  #  #